ASCO meeting for ONYX-015 is scheduled for an
oral presentation on May 16th at 1:30 EDT (in Atlanta)
for the phase II chemotherapy/ONYX-015 combination
trials for Head and Neck cancer. Poster sessions with
ONYX-015 results in a phase I trial for Pancreatic
Carcinoma will be on May 16th, and May 18th as a
preliminary report of ONYX-015 administered by mouthwash as a
preventative against Oral Dyslastic Lesions. The stock has
historically risen just before these presentations are given,
and I don't see why it won't now.
here. but there are lot more bulls.
there are people investing on the internet, what do you
think about cancer cure. the internet business is not
as real as a cure for detrimental disease. internet
is about billions of dollars, cancer cure is about
millions of lives, how how much does is yours worth?
lets face the facts, this is 'real news over old
news'. combine the new and the old, it's great news.
ONXX is now in advanced Phase II trials
humans. This paper
simply elucidated that the trials
are proceeding much
better than expected, via
It also indicates that the drug has
degree of indication. That is NEW
Unlike Entremed, the drug/virus is now in humans
in rodents). We're that much closer to
They have done the samething thousands of drugs
and treatments have done before looked promising in
testing, which is far from being marketed or approved. The
paper and research was already done they just made a
presentation. Only about one in 10000 treatments ever make it
to market none the less go over well. This is not a
new thing don't go bust on this. This was old news
1.)This stock will at least triple tomorrow
Makes sense.... they cured cancer right? Worth any
2.)I do expect to see this stock going above and
Since it's is already in clinic trial and
disease. Now is the best time to
buy, even at $30 or $40, if I have the
Again, makes a good case... cure for cancer after all...
hey this guy sounds credible!
3.) I will hold
this like I am holding Yahoo(Gold online).
Awww crap.... just another on line
DRMD, CYTL and GERN were significantly
DRMD's runup was because of an estrogen replacement drug
- hardly as significant to the human
CYTL and GERN's runups were caused by favorable
results in mouse studies, in early phase clinical
ONXX is about specific successes in reducing and
elminating cancer in humans. Do you see the difference? This
isn't about "maybes", but reality. I agree that lots of
us have seen this coming, but the fruition is what
sets this one apart. By all rights, this should be
MUCH bigger than Viagra. The people that buy in under
$50 will be multi-millionares, and they don't even
need to be scientists - the Reuters article put it in